The cellular interaction of 5-flourouracil and cisplatin in a human colon carcinoma cell line

European Journal of Cancer Part A

Volumn 32, Issue 12, 1996, Pages 2148-2154

  Johnston, P G ^a,b   Geoffrey, F ^a   Drake, J ^a   Voeller, D ^a   Grem, J L ^a   Allegra, C J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

5 flourouracil; cisplatin; human colon carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; THYMIDINE;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DRUG INTERACTION; DRUG POTENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; CELL DIVISION; CISPLATIN; COLONIC NEOPLASMS; DNA DAMAGE; DNA, NEOPLASM; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; FLUOROURACIL; FOLIC ACID; HUMANS; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0030298091     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00266-3     Document Type: Article

References (36)

1. 1. Dreyfuss AI, Clark JR, Wright J, et al. Continuous infusion high dose leucovorin with 5-FU cisplatin for untreated stage 4 carcinoma of the head and neck. Anal Intern Med 1991, 112, 167-172.
2. 2. Forastiere AA, Metch B, Schuller DE, et al. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a South West Oncology Group Study. J Clin Oncol 1992, 10, 1245-1251.
3. 3. Kemeny N, Israel K, NiedZwiecki D, et al. Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer. J Clin Oncol 1990, 8, 313-318.
4. 4. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus. Final report. J Clin Oncol 1993, 11, 1118-1123.
5. 5. Schabel FM, Trader MW, Iaster WR, Corbett TH, Gruswold DP. Cisdichlorodiammineplatinum(11): combination chemotherapy and cross-resistance studies with tumors in mice. Cancer Treat Rep 1979, 63, 1459-1473.
6. 6. Danenberg PV. Thymidylate synthase - a target enzyme in cancer chemotherapy. Biochem Biophys Acta 1977, 473, 73-92.
7. 7. Santi DV, McHenry CS, Sommer M. Mechanisms of interaction of thymidylate synthase with 5 fluorodeoxyuridylate, Biochemistry 1974, 13, 471-480.
8. 8. Lockshin A, Danenberg PV. Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthase. Biochem Pharmacol 1981, 30, 247-257.
9. 9. Houghton JA, Maroda SJ, Phillips JO, Houghton PJ. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res 1981, 41, 144-149.
10. 10. Grem JL. Fluorinated pyrimidines. In Chabner BA, Collins, JM, eds. Cancer Chemotherapy, Principles and Practice. Philadelphia, J.B. Lippincott Co., 1990, 180-224.
11. 11. Roberts JJ, Thomson AJ. Mechanism of action of antitumor platinum compounds. Prog Nucleic Acid Res Mol Biol 1979, 22, 71-133.
12. 12. Scanlon KJ, Newman EM, Lu Y, Priest DG. Biochemical basis for cisplatin and fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986, 83, 8923-8925.
13. 13. Etienne MC, Berenard JL, Fischel P, et al. Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines. Br J Cancer 1991, 63, 372-377.
14. 14. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M. Metabolic basis of the synergistic antitumour activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Chemother Pharmacol 1993, 32, 167-172.
15. 15. Kuroki M, Kanano S, Mitsugi K, et al. In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line. Cancer Chemother Pharmacol 1992, 29, 273-276.
16. 16. Palmeri Trave F, Russello O, Rustum YM. The role of drug sequence in therapeutic selectivity of the combination of fluorouracil and cis-platin. Sel Cancer Ther 1989, 5, 169-177.
17. 17. Johnston P, Allegra C. The interaction of 5-fluorouracil and cisplatin in human carcinoma cells. Proc Am Assoc Cancer Res 1990, 31, 2497.
18. 18. Pratesi G, Gianni L, Manzotti C, Zunino F. Sequence dependence of antitumor and toxic effects of 5-fluorouracil and cisdiamminedichloroplatinum combination on primary colon tumors in mice. Cancer Chemother Pharmacol 1988, 21, 237-240.
19. 19. Esaki T, Kanano S, Tatsumoto T, et al. Inhibition by 5-fluorouracil of cis-diamminedichloroplatinum (11) induced DNA interstarand crosslink removal in a HST-1 human squamous carcinoma cell line. Cancer Res 1992, 52, 6501-6506.
20. 20. Park JG, Oie HK, Sugarbaker PH, et al. Characterisation of cell lines established for human colorectal carcinoma. Cancer Res 1987, 47, 6710-6718.
21. 21. Chou TC, Talalay P. Quantitative analysis of dose effect relationships: the combined effects of multiple drugs or enzymes inhibitors. In Weber G, ed. Advances in Enzyme Regulation. New York, Pergamon Press, 1983, 27-55.
22. 22. Johnston PG, Liang CM, Henry S, Chabner BA, Allegra CJ. The production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissues. Cancer Res 1991, 51, 6668-6676.
23. 23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
24. 24. Swain SM, Lippman ME, Egan EF, Drake JC, Steinberg SM, Allegra CJ. Fluorouracil and high dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 1989, 7, 890-899.
25. 25. Moran RG, Spears CP, Heidelberger C. Biochemical determinants of tumor sensitivity to 5-fluorouracil; ultrasensitive methods for the determination of 5-fluoro-2-deoxyuridylate and thymidylate synthase. Proc Natl Acad Sci USA 1979, 76, 1456-1460.
26. 26. Spears CP, Antranik AH, Moran RG, Heidelberger C, Corbett TH. In vivo kinetics of thymidylate synthase inhibition in 5 fluorouracil sensitive and resistant murine colon adenocarcinomas. Cancer Res 1982, 42, 450-456.
27. 27. Bradford M. MA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analyt Biochem 1976, 72, 248-254.
28. 28. Pogolotti AL, Nolan PA, Santi DV. Methods for complete analysis of 5-fluorouracil metabolites in cell extracts. Analyt Biochem 1981, 117, 178-186.
29. 29. Grem JL, Fischer PH. Alteration of fluorouracil metabolism in human colon carcinoma cancer cells by dipyrimidole with selective increase in fluorodeoxyuridylate monophosphate levels. Cancer Res 1986, 46, 6191-6199.
30. 30. Garrett C, Santi DV. A rapid and sensitive high pressure liquid chromatography assay for deoxyribonucleoside triphosphates in cell extracts. Analyt Biochem 1979, 99, 268-273.
31. 31. Boarman DM, Allegra CJ. Intracellular metabolism of 5-for-myltetrahydrofolate in human breast and colon cell lines. Cancer Res 1992, 52, 36-44.
32. 32. Erickson L, Ross W, Kohn K. Isolation and purification of large quantities of DNA replilcation intermediates by pH step alkaline elution. Chromosoma (Berl) 1979, 74, 126-139.
33. 33. Kohn K, Erickson LC, Ewig RAG, Friedman CA. Fraction of DNA from mammalian cells by alkaline elution. Biochemistry 1981, 15, 4629-4637.
34. 34. van der Wilt C, van Laar JAM, Gyergyay F, Smid K, Peters GJ. Biochemical modification of the toxicity and anti-tumour effect of 5-fluorouracil and cisplatin by WR 2721. Eur J Cancer 1992, 28A, 2017-2024.
35. 35. Ayusawa D, Shimizu K, Koyami H, Takeishi K, Seno T. Accumulation of DNA strand breaks during thymineless death in thymidylate synthase-negative mutants of mouse FM3Aa cells. J Biol Chem 1983, 258, 12448-12454.
36. 36. Johnston PG, Takimoto CH, Grem JL, Chabner BA, Allegra CJ, Chu E. Antimetabolites. In Pinedo HM, Longo DL, Chabner BA, eds. Cancer Chemotherapy and Biological Response Modifiers, Volume 16. Elsevier, The Netherlands, 1996, 16, 1-29.